DE69218246T2 - Pyridylguanidine verbindungen zur behandlung von erektionsstörungen - Google Patents

Pyridylguanidine verbindungen zur behandlung von erektionsstörungen

Info

Publication number
DE69218246T2
DE69218246T2 DE69218246T DE69218246T DE69218246T2 DE 69218246 T2 DE69218246 T2 DE 69218246T2 DE 69218246 T DE69218246 T DE 69218246T DE 69218246 T DE69218246 T DE 69218246T DE 69218246 T2 DE69218246 T2 DE 69218246T2
Authority
DE
Germany
Prior art keywords
erectional
disorders
treating
pyridylguanidine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69218246T
Other languages
English (en)
Other versions
DE69218246D1 (de
Inventor
Allen E Buhl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of DE69218246D1 publication Critical patent/DE69218246D1/de
Application granted granted Critical
Publication of DE69218246T2 publication Critical patent/DE69218246T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
DE69218246T 1991-12-23 1992-12-02 Pyridylguanidine verbindungen zur behandlung von erektionsstörungen Expired - Fee Related DE69218246T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81670091A 1991-12-23 1991-12-23
PCT/US1992/010254 WO1993012788A1 (en) 1991-12-23 1992-12-02 Pyridylguanidine compounds for treatment of erectile dysfunction

Publications (2)

Publication Number Publication Date
DE69218246D1 DE69218246D1 (de) 1997-04-17
DE69218246T2 true DE69218246T2 (de) 1997-07-17

Family

ID=25221384

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69218246T Expired - Fee Related DE69218246T2 (de) 1991-12-23 1992-12-02 Pyridylguanidine verbindungen zur behandlung von erektionsstörungen

Country Status (12)

Country Link
US (1) US5488059A (de)
EP (1) EP0618798B1 (de)
JP (1) JPH07506333A (de)
KR (1) KR940703666A (de)
AT (1) ATE149834T1 (de)
AU (1) AU661747B2 (de)
CA (1) CA2123312A1 (de)
DE (1) DE69218246T2 (de)
DK (1) DK0618798T3 (de)
ES (1) ES2099293T3 (de)
GR (1) GR3023448T3 (de)
WO (1) WO1993012788A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
US6063405A (en) * 1995-09-29 2000-05-16 L.A.M. Pharmaceuticals, Llc Sustained release delivery system
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6436944B1 (en) * 1999-09-30 2002-08-20 Pfizer Inc. Combination effective for the treatment of impotence
KR20010076961A (ko) * 2000-01-29 2001-08-17 김제종 성기능장애 예방 및 치료용 약제
EP1917244A2 (de) 2005-08-24 2008-05-07 Abbott GmbH & Co. KG Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment

Also Published As

Publication number Publication date
DK0618798T3 (da) 1997-09-22
KR940703666A (ko) 1994-12-12
CA2123312A1 (en) 1993-07-08
AU661747B2 (en) 1995-08-03
US5488059A (en) 1996-01-30
AU3149793A (en) 1993-07-28
WO1993012788A1 (en) 1993-07-08
ATE149834T1 (de) 1997-03-15
ES2099293T3 (es) 1997-05-16
EP0618798A1 (de) 1994-10-12
JPH07506333A (ja) 1995-07-13
DE69218246D1 (de) 1997-04-17
GR3023448T3 (en) 1997-08-29
EP0618798B1 (de) 1997-03-12

Similar Documents

Publication Publication Date Title
CO5050298A1 (es) Metodo y composicion para tratar impotencia
DK0480934T3 (da) Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
ATE110958T1 (de) Verwendung von sertralin zur behandlung verfrühter ejakulation.
CO4290359A1 (es) Metodo para tratar la alopecia androgenica con inhibidores 5-alfa-reductasa
ATE173603T1 (de) Behandlung von erektionversagen
KR910019618A (ko) 발기부전증 치료용 제약 조성물
DE69218246D1 (de) Pyridylguanidine verbindungen zur behandlung von erektionsstörungen
EA200200324A1 (ru) Способы применения селективных ингибиторов обратного захвата серотонина быстрого запуска для лечения половой дисфункции
DE69210654D1 (de) Verwendung von Tomoxetine zur Behandlung von Funktionsstörungen der niedrigen Harnwege
DE69739970D1 (de) Methode zur behandlung sexueller fehlfunktionen
ATE152621T1 (de) Behandlungsverfahren kataboler dysfunktion
DE69316013T2 (de) Verwendung von phosphinate zur behandlung der osteoporose
AP9100336A0 (en) Method for the treatment ofnematodes in soil using furfural.
SE9202208D0 (sv) Vaevnadsfoerstaerkning
ES2171419T3 (es) Uso de los inhibidores del citocromo p450 para inhibir el metabolismo del nitrogeno sustituido acridina.
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren
EE9800315A (et) Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
ATE149840T1 (de) Behandlung von leberkrebs
ATE183095T1 (de) Verwendung von prostaglandin-e1 zur behandlung männlicher erektiler impotenz
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom
RU96122672A (ru) Эхинамакс. способ лечения астенических состояний при физиогенных дезадаптациях
EA200000514A1 (ru) Способ лечения эректильной дисфункции
MX9706404A (es) Metodo para tratar deplecion de adenosina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee